Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nippon India Nifty Pharma ETF Share Price
Day's Range
Day's Range
Low
₹24.59
High
₹25.30
Price Summary
| Previous Close | ₹24.66 |
|---|---|
| Day's Range | ₹24.59 - ₹25.30 |
| Open | ₹24.81 |
| 52 Week Range | N/A - N/A |
| Volume | 35,37,283 |
| Market Cap |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 872.29 |
|---|---|
| Market Cap (₹ in Mn) | |
| Dividend Yield(%) | |
| Price/Earning (TTM) | |
| TTM EPS (₹) | |
| P/E Ratio | |
| Book Value(₹) | |
| PAT Margin (%) | |
| Face Value (₹) | |
| ROCE(%) |
About Nippon India Nifty Pharma ETF
| NSE Symbol | PHARMABEES |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|
No Records Found
Latest News
Currency futures for May expiry trade weaker with 2.68% increase in OI
Vibhor Steel Tubes informs about board meeting
Vibhor Steel Tubes has informed that a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 20th May 2026, to consider and approve: • The Audited Standalone Financial Results for the Fourth Quarter and Financial Year Ended 31st March 2026, along with the Reports of Auditors thereon and. • Any other business with the permission of the Chair. Further, in continuation of its letter dated 23rd March 2026, the Trading Window in respect of dealing in the Company’s Securities was closed for all Directors/Designated Employees and its connected persons from the opening of the trading hours on Tuesday, 1st April, 2026, which shall remain closed till the closure of trading hours on 22nd May, 2026 i.e. till the completion of 48 hours after conclusion of the Board meeting as per the policy for prohibition of Insider Trading (‘the Code’) adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time.
Sportking India informs about earnings call
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sportking India has informed that an earnings call will be held on Tuesday, 19th May, 2026 at 03.00 pm (IST) to discuss the operational and financial performance of the Company for Fourth Quarter and Financial Year ended 31st March, 2026. Details of the same are mentioned in the call Invite enclosed and is also available on the website of the Company at www.sportking.co.in.
NDR Auto Components informs about newspaper publication
Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, NDR Auto Components has informed that it enclosed copy of the Audited Financial Results for the quarter and year ended March 31, 2026 published in newspapers, Financial Express (English newspaper) and Jansatta (Hindi newspaper) on May 12, 2026, which were duly approved in the meeting of the Board of Directors held on May 11, 2026.
The above information is a part of company’s filings submitted to BSE.
Anand Rathi Wealth informs about disclosure
Anand Rathi Wealth has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on May 11, 2026 for Anand Rathi Financial Services.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Nippon India Nifty Pharma ETF is ₹24.66 as of 2026-05-12.
The market capitalisation of Nippon India Nifty Pharma ETF is ₹ as of .
The 1-year return of Nippon India Nifty Pharma ETF is -0.15% as of 2026-05-12.
The P/E ratio of Nippon India Nifty Pharma ETF is as of .
The 52-week high and low of Nippon India Nifty Pharma ETF are ₹ and ₹, respectively, as of 2026-05-12.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
